Islamic scholar Tariq Ramadan to face French judge

Islamic scholar Tariq Ramadan to face French judge
Tariq Ramadan. (AFP)
Updated 02 February 2018

Islamic scholar Tariq Ramadan to face French judge

Islamic scholar Tariq Ramadan to face French judge

PARIS: Prominent Islamic scholar Tariq Ramadan will face a French investigating magistrate Friday after two days of questioning over claims by two women that he raped them in French hotel rooms in 2009 and 2012.
The judge may then formally charge the 55-year-old Oxford professor over the allegations which emerged in the wake of the Harvey Weinstein scandal, a judicial source told AFP.
Ramadan, a Swiss citizen whose grandfather founded Egypt’s Muslim Brotherhood movement, was taken into custody Wednesday as part of a preliminary enquiry in Paris into the rape and assault allegations.
A regular face on French television, he is the most prominent figure to be held in France over the sexual assault and harassment claims that have rippled around the world as a result of the “Me Too” campaign.
Ramadan has denied the separate accusations from the two women.
The first was made by Henda Ayari, a feminist activist who previously practiced a conservative strain of Islam. She had described being raped in a book published in 2016, without naming her attacker.
But in October, she said she had decided to name Ramadan publicly as the alleged perpetrator as a result of the “Me Too” campaign, using the French hashtag “Balance Ton Porc” (Expose your pig).
She said Ramadan raped her in his hotel room, telling Le Parisien newspaper: “He choked me so hard that I thought I was going to die.”
She lodged a rape complaint against Ramadan on October 20.
Several days later an unidentified disabled woman, a Muslim convert, also accused the academic of violently raping her in a hotel room in the southeastern city of Lyon in 2009.
Vanity Fair magazine, which met the woman, said her lawsuit against Ramadan described “blows to the face and body, forced sodomy, rape with an object and various humiliations, including being dragged by the hair to the bathtub and urinated on.”
During three hours of testimony in Paris on Thursday, the woman — using the pseudonym “Christelle” — recounted her allegations to the judge in Ramadan’s presence.
Rejecting her testimony, the scholar refused to sign the official summary of the account, sources close to the case said.
“Both sides maintained their positions,” one source said.
During three months of investigations since the allegations emerged, police have interviewed dozens of people close to both Ramadan and the two women, and examined email and social media exchanges between them.
In November, Oxford University said Ramadan was taking a leave of absence from his post as professor of contemporary Islamic studies, “by mutual agreement.”
He has also denied allegations in Swiss media of sexual misconduct against teenage girls in the 1980s and 1990s, denouncing them as “a campaign of lies launched by my adversaries.”
Lawyers for Ramadan, a married father of four, have accused Ayari of slander and suggested the women colluded to try to disgrace him.
As part of his defense he has presented investigators with Facebook conversations in which a woman identified as Ayari allegedly made explicit advances toward him in 2014, two years after the alleged rape.
The accusations have sparked heated online debate between supporters of Ramadan, who commands a following of more than two million fans on Facebook, and his opponents.
Ayari was placed under police protection in November after receiving death threats.
Ramadan continues to head the Islamic Institute for Ethical Training in France.


Russia’s second coronavirus vaccine ‘100% effective’, watchdog tells media

Russia’s second coronavirus vaccine ‘100% effective’, watchdog tells media
Updated 20 min 4 sec ago

Russia’s second coronavirus vaccine ‘100% effective’, watchdog tells media

Russia’s second coronavirus vaccine ‘100% effective’, watchdog tells media
  • ‘The effectiveness of the vaccine is made up of its immunological effectiveness and preventative effectiveness’

MOSCOW: A candidate COVID-19 vaccine known as EpiVacCorona, Russia’s second to be registered, proved “100 percent effective” in early-stage trials, Russian consumer health watchdog Rospotrebnadzor has told local media.
The data, based on Phase I and II trials, were released before the start of a larger Phase III trial which would normally involve thousands of participants and a placebo group as a comparison.
“The effectiveness of the vaccine is made up of its immunological effectiveness and preventative effectiveness,” the TASS news agency reported, citing Rospotrebnadzor.
“According to results of the first and second phases of clinical trials, the immunological effectiveness of the EpiVacCorona vaccine is 100 percent.”
The Phase I and II studies tested the safety, reactogenicity and immunogenicity of the potential vaccine in 100 people aged 18-60, according to the state trials register.
Russia began testing EpiVacCorona, which is being developed by Siberia’s Vector Institute, in November.
Earlier that month, Moscow said its other approved vaccine, Sputnik V, was 92 percent effective at protecting people from COVID-19 based on interim results.
Russia has said it can inoculate 60 percent of its population against COVID-19 this year, and although the Sputnik V vaccine has been readily available in Moscow, the rollout across the country has been slow.
Russian President Vladimir Putin has ordered mass vaccinations to start this week.
EpiVacCorona will be used in mass vaccinations from March, Deputy Prime Minister Tatiana Golikova told the Interfax news agency.
Russia has reported 3,612,800 coronavirus cases, the world’s fourth-highest total. Its death toll from the virus stands at 66,623.